Roche Madison, 500 S Rosa Rd, Madison, WI, 53719, USA.
Roche Pharmaceutical Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, Grenzacherstrasse, 4070, Basel, Switzerland.
Sci Rep. 2017 Sep 21;7(1):12116. doi: 10.1038/s41598-017-12440-1.
Considerable efforts have been made to develop technologies for selection of peptidic molecules that act as substrates or binders to a protein of interest. Here we demonstrate the combination of rational peptide array library design, parallel screening and stepwise evolution, to discover novel peptide hotspots. These hotspots can be systematically evolved to create high-affinity, high-specificity binding peptides to a protein target in a reproducible and digitally controlled process. The method can be applied to synthesize both linear and cyclic peptides, as well as peptides composed of natural and non-natural amino acid analogs, thereby enabling screens in a much diverse chemical space. We apply this method to stepwise evolve peptide binders to streptavidin, a protein studied for over two decades and report novel peptides that mimic key interactions of biotin to streptavidin.
人们已经做出了相当大的努力来开发技术,以选择作为感兴趣的蛋白质的底物或配体的肽分子。在这里,我们展示了合理的肽阵列文库设计、平行筛选和逐步进化的结合,以发现新的肽热点。这些热点可以通过系统进化来创建高亲和力、高特异性的结合肽,以在可重复和数字控制的过程中针对蛋白质靶标。该方法可用于合成线性和环状肽,以及由天然和非天然氨基酸类似物组成的肽,从而能够在更广泛的化学空间中进行筛选。我们将该方法应用于逐步进化到链霉亲和素的肽结合物,链霉亲和素是一种被研究了二十多年的蛋白质,并报告了模拟生物素与链霉亲和素关键相互作用的新型肽。